第一单位：
Department of Medicine, NYU Langone Health, New York, New York.;Perlmutter Cancer Center, NYU Langone Health, New York, New York.
作者：
Paul E,Oberstein [1]
;
Andressa,Dias Costa [2]
;
Emily A,Kawaler [3]
;
Victoire,Cardot-Ruffino [4]
;
Osama E,Rahma [5]
;
Nina,Beri [1]
;
Harshabad,Singh [5]
;
Thomas A,Abrams [5]
;
Leah H,Biller [5]
;
James M,Cleary [5]
;
Peter,Enzinger [5]
;
Brandon M,Huffman [5]
;
Nadine J,McCleary [5]
;
Kimberly J,Perez [5]
;
Douglas A,Rubinson [5]
;
Benjamin L,Schlechter [5]
;
Rishi,Surana [5]
;
Matthew B,Yurgelun [5]
;
S Jennifer,Wang [6]
;
Joshua,Remland [2]
;
Lauren K,Brais [2]
;
Naima,Bollenrucher [6]
;
Eugena,Chang [6]
;
Lestat R,Ali [7]
;
Patrick J,Lenehan [4]
;
Igor,Dolgalev [1]
;
Gregor,Werba [3]
;
Cibelle,Lima [2]
;
C Elizabeth,Keheler [8]
;
Keri M,Sullivan [8]
;
Michael,Dougan [8]
;
Cristina,Hajdu [9]
;
Maya,Dajee [10]
;
Marc R,Pelletier [10]
;
Saloney,Nazeer [11]
;
Matthew,Squires [11]
;
Dafna,Bar-Sagi [1]
;
Brian M,Wolpin [5]
;
Jonathan A,Nowak [12]
;
Diane M,Simeone [3]
;
Stephanie K,Dougan [4]
作者单位：
Department of Medicine, NYU Langone Health, New York, New York.;Perlmutter Cancer Center, NYU Langone Health, New York, New York.
[1]
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
[2]
Perlmutter Cancer Center, NYU Langone Health, New York, New York.;Department of Surgery, NYU Langone Health, New York, New York.
[3]
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Department of Immunology, Harvard Medical School, Boston, Massachusetts.
[4]
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.;Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
[5]
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[6]
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Department of Immunology, Harvard Medical School, Boston, Massachusetts.;Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
[7]
Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
[8]
Perlmutter Cancer Center, NYU Langone Health, New York, New York.;Department of Pathology, NYU Langone Health, New York, New York.
[9]
Novartis Institute for Biomedical Research, Cambridge, Massachusetts.
[10]
Novartis Pharmaceuticals, Cambridge, Massachusetts.
[11]
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.;Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
[12]
DOI
10.1158/2326-6066.CIR-23-1073
PMID
38990554
发布时间
2026-04-18
换一批
